胞外超氧化物歧化酶(SOD3)重組蛋白
Recombinant Superoxide Dismutase 3, Extracellular (SOD3)
SOD-3; EC-SOD; Extracellular Superoxide Dismutase Cu-Zn
- 編號URPA117Hu03
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位分泌
- 預(yù)測分子量37.9kDa
- 實(shí)際分子量40kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Trp19~Ala240 with Two N-terminal Tags, His-tag and SUMO-tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)6.3
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 486 ¥ 1215 ¥ 2430 ¥ 7290 ¥ 18225
- 欲了解實(shí)際交易價(jià)格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure . Gene Sequencing (extract)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月，-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| UAPA117Hu01 | 胞外超氧化物歧化酶(SOD3)活性蛋白 | Cell?culture;?Activity?Assays. |
| UAPA117Hu62 | 胞外超氧化物歧化酶(SOD3)活性蛋白 | Cell?culture;?Activity?Assays. |
| UAPA117Hu03 | 胞外超氧化物歧化酶(SOD3)活性蛋白 | Cell?culture;?Activity?Assays. |
| UAPA117Hu04 | 胞外超氧化物歧化酶(SOD3)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPA117Hu01 | 胞外超氧化物歧化酶(SOD3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UEPA117Hu61 | 胞外超氧化物歧化酶(SOD3)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA117Hu02 | 胞外超氧化物歧化酶(SOD3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA117Hu03 | 胞外超氧化物歧化酶(SOD3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA117Hu04 | 胞外超氧化物歧化酶(SOD3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPA117Hu61 | 胞外超氧化物歧化酶(SOD3)活性蛋白 | Cell?culture;?Activity?Assays. |
| UPAA117Hu01 | 胞外超氧化物歧化酶(SOD3)多克隆抗體 | WB; IHC |
| ULAA117Hu71 | 胞外超氧化物歧化酶(SOD3)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| UMAA117Hu23 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | IHC |
| UMAA117Hu24 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | IHC; ICC/IF |
| UMAA117Hu25 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | IHC; ICC/IF |
| UMAA117Hu22 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | WB |
| UMAA117Hu21 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | WB |
| UMAA117Hu27 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | IHC |
| USEA117Hu | 胞外超氧化物歧化酶(SOD3)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMA117Hu | 胞外超氧化物歧化酶(SOD3)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Current Alzheimer Research | Comparison of Extracellular and Intracellular Blood Compartments Highlights Redox Alterations in Alzheimer's and Mild Cognitive Impairment Patients. [pubmed:27748187] |
| Frontiers in Microbiology | Burn Serum Increases Staphylococcus aureus Biofilm Formation via Oxidative Stress. [pubmed:28702016] |
| Nature?Communications | SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α [Pubmed:29422508] |
| BMC?Neuroscience | Neuroprotective dobutamine treatment upregulates superoxide dismutase 3, anti-oxidant and survival genes and attenuates genes mediating inflammation [Pubmed:29523072] |
| Diabetes-Metabolism?Research?and Reviews | Myeloperoxidase, superoxide dismutase‐3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study [Pubmed:29577557] |
| Advances in Medical Sciences | Selected elements of extracellular matrix of the skin in diabetes and insulin resistance [Pubmed: 31146169] |
| Clinical Kidney Journal | Serum uromodulin is inversely associated with biomarkers of subclinical inflammation in the population-based KORA F4 study [] |
| PLoS One | Association of circulating MR-proADM with all-cause and cardiovascular mortality in the general population: Results from the KORA F4 cohort study [Pubmed:34990470] |
| ORIGINAL RESEARCH PATHOPHYSIOLOGY | EFFECTS OF HIS-PHE-ARG-TRP-PRO-GLY-PRO PEPTIDE ON FREE-RADICAL OXIDATION PROCESSES IN CONDITIONS OF CHRONIC RESTRAINT?… [] |
留言咨詢
